Is Ocugen a good investment?

How effective is Ocugen vaccine?

The vaccine demonstrated efficacy in mild, moderate and severe COVID-19 of 77.8% with efficacy against severe disease of 93.4%. The vaccine is already being used in India under a restricted emergency use authorization. Ocugen reportedly plans to file for approval in the U.S. and Canada.

Will Ocugen get FDA approval for Covaxin?

The Phase III trial will analyse the safety and tolerability of Covaxin in subjects in the US.

Who makes Ocugen vaccine?

Ocugen’s COVID-19 Vaccine Co-Development Partner, Bharat Biotech, Shares Phase 3 Results Demonstrating 77.8% Protection against Overall Disease.

Is Covaxin made by Ocugen?

Ocugen and Bharat Biotech to Co-Develop BBV152, known as COVAXIN™ candidate outside of the U.S., a Whole-Virion Inactivated COVID-19 Vaccine, for the US Market.

Is Covaxin safe?

Covaxin is an inactivated vaccine which means that it is made up of killed coronaviruses, making it safe to be injected into the body.

What does Ocugen Inc do?

About Ocugen Inc

Ocugen, Inc. is a biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing vaccine for COVID-19.

WHO approved vaccine list?

World Health Organization (WHO)

  • Moderna. mRNA-1273. Phase 1. …
  • Pfizer/BioNTech. BNT162b2. Phase 1. …
  • Janssen (Johnson & Johnson) Ad26.COV2.S. Phase 1. …
  • Oxford/AstraZeneca. AZD1222. Phase 1. …
  • Serum Institute of India. Covishield (Oxford/AstraZeneca formulation) Phase 1. …
  • Sinopharm (Beijing) BBIBP-CorV (Vero Cells) Phase 1. …
  • Sinovac. CoronaVac.
THIS IS INTERESTING:  Where do LIC invest their money?